FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
24.32 USD
0.88 (3.62%)
XOMA Financial Statements
Year
2024
2023
2022
2021
Current Assets
125.6M
169.31M
61.25M
96.97M
Cash & Short Term Investments
105.18M
153.45M
58.16M
94.1M
Cash And Cash Equivalents
101.65M
153.29M
57.83M
93.33M
Short Term Investments
3.53M
161k
335k
774k
Net Receivables
17.02M
15.22M
2.37M
209k
Inventory
0
0
1
2.05M
Other Current Assets
2.08M
643k
725k
2.05M
Non-Current Assets
95.67M
64.99M
79.13M
69.59M
Property, Plant & Equipment
351k
403k
36k
213k
Goodwill And Intangible Assets
25.91M
0
15.15M
0
Goodwill
0
0
0
0
Intangible Assets
25.91M
0
15.15M
0
Long Term Investments
0
0
63.68M
69.08M
Tax Assets
0
0
-63.68M
0
Other Non-Current Assets
69.41M
64.58M
63.94M
301k
Other Assets
0
0
0
0
Total Assets
221.28M
234.3M
140.38M
166.56M
-
-
-
-
Current Liabilities
24.37M
19.5M
6.82M
12.97M
Accounts Payable
1.05M
653k
524k
1.07M
Short Term Debt
11.39M
5.54M
34k
195k
Tax Payables
280k
0
0
91k
Deferred Revenue
1.36M
2.11M
1.9M
1.64M
Other Current Liabilities
8.92M
9.78M
2.32M
9.67M
Total Current Liabilities
24.37M
19.5M
6.82M
12.97M
Total Non-Current Liabilities
114.98M
126.08M
9.55M
11.72M
Long-Term Debt
106.88M
118.52M
0
0
Deferred Revenue
0
7.23M
9.55M
11.69M
Deferred Taxes Liabilities
0
0
0
-11.69M
Other Non Current liabilities
8.11M
0
0
0
Total Liabilities
139.36M
145.58M
16.37M
24.69M
Other Liabilities
0
0
0
0
Stockholders Equity
81.92M
88.72M
124.01M
141.88M
Common Stock
90k
86k
86k
85k
Retained Earnings
-1.24B
-1.22B
-1.18B
-1.17B
Accumulated Other Comprehensive Income/Loss
73k
0
0
0
Other Shareholders Equity
1.32B
0
0
0
Total Liabilities and Stockholders Equity
221.28M
234.3M
140.38M
166.56M
All figures are in USD.
